83,022 Shares in Corteva, Inc. $CTVA Purchased by Cibc World Market Inc.

Cibc World Market Inc. acquired a new stake in Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 83,022 shares of the company’s stock, valued at approximately $7,031,000.

A number of other hedge funds also recently made changes to their positions in CTVA. Arbejdsmarkedets Tillaegspension bought a new position in Corteva in the 4th quarter valued at about $23,679,000. Bank of New York Mellon Corp bought a new stake in shares of Corteva during the second quarter worth approximately $392,447,000. Leonteq Securities AG bought a new stake in shares of Corteva during the fourth quarter worth approximately $2,350,000. Brandes Investment Partners LP grew its position in shares of Corteva by 1.1% in the fourth quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company’s stock valued at $155,009,000 after purchasing an additional 24,985 shares during the last quarter. Finally, Twin Capital Management Inc. increased its stake in shares of Corteva by 178.9% during the fourth quarter. Twin Capital Management Inc. now owns 25,394 shares of the company’s stock worth $1,702,000 after purchasing an additional 16,288 shares during the period. 81.54% of the stock is owned by institutional investors and hedge funds.

Corteva Trading Up 0.4%

Shares of CTVA stock opened at $83.18 on Wednesday. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. The stock has a market cap of $55.50 billion, a P/E ratio of 55.09, a price-to-earnings-growth ratio of 2.54 and a beta of 0.57. The stock has a 50 day simple moving average of $82.39 and a 200 day simple moving average of $80.37. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $90.97.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The firm had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company’s revenue was down 1.2% on a year-over-year basis. During the same quarter last year, the company earned $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, research analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be given a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is presently 47.68%.

Wall Street Analyst Weigh In

Several research firms recently weighed in on CTVA. CICC Research lifted their price target on Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Barclays upped their price objective on Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a report on Thursday, June 11th. UBS Group dropped their target price on Corteva from $89.00 to $85.00 and set a “neutral” rating for the company in a report on Tuesday, August 18th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $101.00 target price on shares of Corteva in a research report on Monday, August 3rd. Finally, JPMorgan Chase & Co. upped their price target on shares of Corteva from $77.00 to $83.00 and gave the company a “neutral” rating in a research note on Monday, August 3rd. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Corteva presently has an average rating of “Moderate Buy” and a consensus target price of $91.50.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.